GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MiMedx Group Inc (NAS:MDXG) » Definitions » E10

MDXG (MiMedx Group) E10 : $-0.04 (As of Sep. 2024)


View and export this data going back to 2008. Start your Free Trial

What is MiMedx Group E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

MiMedx Group's adjusted earnings per share data for the three months ended in Sep. 2024 was $0.050. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.04 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average E10 Growth Rate was 5.00% per year. During the past 5 years, the average E10 Growth Rate was -42.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of MiMedx Group was 71.20% per year. The lowest was -115.40% per year. And the median was 5.00% per year.

As of today (2024-12-11), MiMedx Group's current stock price is $9.46. MiMedx Group's E10 for the quarter that ended in Sep. 2024 was $-0.04. MiMedx Group's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of MiMedx Group was 640.00. The lowest was 0.00. And the median was 526.00.


MiMedx Group E10 Historical Data

The historical data trend for MiMedx Group's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MiMedx Group E10 Chart

MiMedx Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.07 -0.07 -0.10 -0.06

MiMedx Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.10 -0.06 -0.05 -0.04 -0.04

Competitive Comparison of MiMedx Group's E10

For the Biotechnology subindustry, MiMedx Group's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MiMedx Group's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MiMedx Group's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where MiMedx Group's Shiller PE Ratio falls into.



MiMedx Group E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, MiMedx Group's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.05/133.0289*133.0289
=0.050

Current CPI (Sep. 2024) = 133.0289.

MiMedx Group Quarterly Data

per share eps CPI Adj_EPS
201412 0.030 99.070 0.040
201503 0.040 99.621 0.053
201506 0.050 100.684 0.066
201509 0.060 100.392 0.080
201512 0.120 99.792 0.160
201603 0.010 100.470 0.013
201606 0.020 101.688 0.026
201609 0.030 101.861 0.039
201612 -0.057 101.863 -0.074
201703 0.040 102.862 0.052
201706 0.070 103.349 0.090
201709 0.150 104.136 0.192
201712 0.300 104.011 0.384
201803 0.040 105.290 0.051
201806 0.020 106.317 0.025
201809 -0.002 106.507 -0.002
201812 -0.340 105.998 -0.427
201903 -0.120 107.251 -0.149
201906 -0.160 108.070 -0.197
201909 0.110 108.329 0.135
201912 -0.070 108.420 -0.086
202003 -0.040 108.902 -0.049
202006 -0.080 108.767 -0.098
202009 -0.480 109.815 -0.581
202012 -0.170 109.897 -0.206
202103 -0.090 111.754 -0.107
202106 -0.030 114.631 -0.035
202109 -0.040 115.734 -0.046
202112 0.010 117.630 0.011
202203 -0.110 121.301 -0.121
202206 -0.110 125.017 -0.117
202209 -0.090 125.227 -0.096
202212 -0.020 125.222 -0.021
202303 -0.060 127.348 -0.063
202306 0.000 128.729 0.000
202309 0.060 129.860 0.061
202312 0.385 129.419 0.396
202403 0.060 131.776 0.061
202406 0.120 132.554 0.120
202409 0.050 133.029 0.050

Add all the adjusted EPS together and divide 10 will get our e10.


MiMedx Group  (NAS:MDXG) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of MiMedx Group was 640.00. The lowest was 0.00. And the median was 526.00.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


MiMedx Group E10 Related Terms

Thank you for viewing the detailed overview of MiMedx Group's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


MiMedx Group Business Description

Traded in Other Exchanges
N/A
Address
1775 West Oak Commons Court, NE, Marietta, GA, USA, 30062
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Executives
Hulse William Frank Iv officer: General Counsel 1775 WEST OAK COMMONS COURT NE, MARIETTA GA 30062
Ricci S Whitlow officer: Chief Operating Officer C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Rice Doug officer: Chief Financial Officer 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Joseph H Capper officer: Chief Executive Officer BIOTELEMETRY, INC., 1000 CEDAR HOLLOW ROAD, #102, MALVERN PA 19355
Robert Benjamin Stein officer: EVP, Research and Development C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON MA 02421
Peter M Carlson officer: Chief Financial Officer BRIGHTHOUSE FINANCIAL, INC., 11225 NORTH COMMUNITY HOUSE ROAD, CHARLOTTE NC 28277
William Lawrence Phelan officer: Chief Accounting Officer 1775 WEST OAK COMMONS COURT NE, MARIETTA GA 30062
Rohit Kashyap officer: EVP & Chief Commercial Officer 8023 VANTAGE DRIVE, SAN ANTONIO TX 78230
Timothy R Wright director, officer: Chief Executive Officer C/O CURAXIS, 1004 CHAGFORD WAY, RALEIGH NC 27614
Mark Graves officer: SVP & Chief Compliance Officer 1775 WEST OAK COMMONS COURT, MARIETTA GA 30062
Scott M Turner officer: SVP, Operations & Procurement 1775 WEST OAK COMMONS COURT, MARIETTA GA 30062
Phyllis Gardner director 618 MIRADA AVENUE, STANFORD CA 94305
Michael J Giuliani director 1775 WEST OAK COMMONS COURT NE, MARIETTA GA 30062
Cato T Laurencin director C/O UNIVERSITY OF CONNECTICUT, 263 FARMINGTON AVENUE, FARMINGTON CT 06030-3800
William A Hawkins director MEDTRONIC INC, 710 MEDTRONIC PKWY, MS LC310, MINNEAPOLIS MN 55432-5604